|
1
|
Wani MC, Taylor HL, Wall ME, Coggon P and
McPhail AT: Plant antitumor agents. VI The isolation and structure
of Taxol, a novel antileukemic and antitumor agent from Taxus
brevifolia. J Am Chem Soc. 93:2325–2327. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schiff PB and Horwitz SB: Taxol assembles
tubulin in the absence of exogenous guanosine 5′-triphosphate or
microtubule-associated proteins. Biochemistry. 20:3247–3252.
1981.PubMed/NCBI
|
|
3
|
Schiff PB and Horwitz SB: Taxol stabilizes
microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA.
77:1561–1565. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cummins JM and Velculescu VE: Implications
of micro-RNA profiling for cancer diagnosis. Oncogene.
25:6220–6227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He H, Jazdzewski K, Li W, et al: The role
of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad
Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Johnson SM, Grosshans H, Shingara J, et
al: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Corney DC, Flesken-Nikitin A, Godwin AK,
Wang W and Nikitin AY: MicroRNA-34b and MicroRNA-34c are targets of
p53 and cooperate in control of cell proliferation and
adhesion-independent growth. Cancer Res. 67:8433–8438. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang TC, Wentzel EA, Kent OA, et al:
Transactivation of miR-34a by p53 broadly influences gene
expression and promotes apoptosis. Mol Cell. 26:745–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Debernardi S, Skoulakis S, Molloy G,
Chaplin T, Dixon-McIver A and Young BD: MicroRNA miR-181a
correlates with morphological sub-class of acute myeloid leukaemia
and the expression of its target genes in global genome-wide
analysis. Leukemia. 21:912–916. 2007.PubMed/NCBI
|
|
14
|
Blower PE, Chung JH, Verducci JS, et al:
MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer
Ther. 7:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng T, Wang J, Chen X and Liu L: Role of
microRNA in anticancer drug resistance. Int J Cancer. 126:2–10.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boren T, Xiong Y, Hakam A, et al:
MicroRNAs and their target messenger RNAs associated with ovarian
cancer response to chemotherapy. Gynecol Oncol. 113:249–255. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng A, Kallio A and Harkonen P:
Tamoxifen-induced rapid death of MCF-7 breast cancer cells is
mediated via extracellularly signal-regulated kinase signaling and
can be abrogated by estrogen. Endocrinology. 148:2764–2777. 2007.
View Article : Google Scholar
|
|
18
|
Ritchie ME, Silver J, Oshlack A, et al: A
comparison of background correction methods for two-colour
microarrays. Bioinformatics. 23:2700–2707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smyth GK and Speed T: Normalization of
cDNA microarray data. Methods. 31:265–273. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bar M, Wyman SK, Fritz BR, et al: MicroRNA
discovery and profiling in human embryonic stem cells by deep
sequencing of small RNA libraries. Stem Cells. 26:2496–2505. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X and El Naqa IM: Prediction of both
conserved and nonconserved microRNA targets in animals.
Bioinformatics. 24:325–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sontheimer EJ and Carthew RW: Silence from
within: endogenous siRNAs and miRNAs. Cell. 122:9–12. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
O’Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005.PubMed/NCBI
|
|
25
|
Blower PE, Verducci JS, Lin S, et al:
MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol
Cancer Ther. 6:1483–1491. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cittelly DM, Dimitrova I, Howe EN, et al:
Restoration of miR-200c to ovarian cancer reduces tumor burden and
increases sensitivity to paclitaxel. Mol Cancer Ther. 11:2556–2565.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Zuo J, Liu Y, Gao H and Liu W:
Inhibitory effects of miRNA-200c on chemotherapy-resistance and
cell proliferation of gastric cancer SGC7901/DDP cells. Chin J
Cancer. 29:1006–1011. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujita Y, Kojima K, Ohhashi R, et al:
MiR-148a attenuates paclitaxel resistance of hormone-refractory,
drug-resistant prostate cancer PC3 cells by regulating MSK1
expression. J Biol Chem. 285:19076–19084. 2010. View Article : Google Scholar
|
|
29
|
Du L, Subauste MC, DeSevo C, et al:
miR-337-3p and its targets STAT3 and RAP1A modulate
taxane sensitivity in non-small cell lung cancers. PLoS One.
7:e391672012.PubMed/NCBI
|
|
30
|
Catuogno S, Cerchia L, Romano G, Pognonec
P, Condorelli G and de Franciscis V: miR-34c may protect lung
cancer cells from paclitaxel-induced apoptosis. Oncogene.
32:341–351. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Holleman A, Chung I, Olsen RR, et al:
miR-135a contributes to paclitaxel resistance in tumor cells both
in vitro and in vivo. Oncogene. 30:4386–4398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Zhang Y, Zhao J, Kong F and Chen Y:
Overexpression of miR-22 reverses paclitaxel-induced
chemoresistance through activation of PTEN signaling in p53-mutated
colon cancer cells. Mol Cell Biochem. 357:31–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou M, Liu Z, Zhao Y, et al:
MicroRNA-125b confers the resistance of breast cancer cells to
paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist
killer 1 (Bak1) expression. J Biol Chem. 285:21496–21507. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mei M, Ren Y, Zhou X, et al:
Downregulation of miR-21 enhances chemotherapeutic effect of taxol
in breast carcinoma cells. Technol Cancer Res Treat. 9:77–86. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang YW, Liu JC, Deatherage DE, et al:
Epigenetic repression of microRNA-129-2 leads to overexpression of
SOX4 oncogene in endometrial cancer. Cancer Res. 69:9038–9046.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mialon A, Sankinen M, Soderstrom H, et al:
DNA topoisomerase I is a cofactor for c-Jun in the regulation of
epidermal growth factor receptor expression and cancer cell
proliferation. Mol Cell Biol. 25:5040–5051. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Barroso-delJesus A, Romero-Lopez C,
Lucena-Aguilar G, et al: Embryonic stem cell-specific miR302–367
cluster: human gene structure and functional characterization of
its core promoter. Mol Cell Biol. 28:6609–6619. 2008.PubMed/NCBI
|
|
38
|
Lavon I, Zrihan D, Granit A, et al:
Gliomas display a microRNA expression profile reminiscent of neural
precursor cells. Neuro Oncol. 12:422–433. 2010.PubMed/NCBI
|
|
39
|
Sokilde R, Kaczkowski B, Podolska A, et
al: Global microRNA analysis of the NCI-60 cancer cell panel. Mol
Cancer Ther. 10:375–384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Greither T, Grochola LF, Udelnow A,
Lautenschlager C, Wurl P and Taubert H: Elevated expression of
microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated
with poorer survival. Int J Cancer. 126:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Levati L, Alvino E, Pagani E, et al:
Altered expression of selected microRNAs in melanoma:
antiproliferative and proapoptotic activity of miRNA-155. Int J
Oncol. 35:393–400. 2009.PubMed/NCBI
|
|
42
|
Pan X, Zhao J, Zhang WN, et al: Induction
of SOX4 by DNA damage is critical for p53 stabilization and
function. Proc Natl Acad Sci USA. 106:3788–3793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Baraniskin A, Birkenkamp-Demtroder K,
Maghnouj A, et al: MiR-30a-5p suppresses tumor growth in colon
carcinoma by targeting DTL. Carcinogenesis. 33:732–739. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Marchini S, Cavalieri D, Fruscio R, et al:
Association between miR-200c and the survival of patients with
stage I epithelial ovarian cancer: a retrospective study of two
independent tumour tissue collections. Lancet Oncol. 12:273–285.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li X, Zhang Y, Zhang Y, Ding J, Wu K and
Fan D: Survival prediction of gastric cancer by a seven-microRNA
signature. Gut. 59:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
